CUPRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Cuprina Holdings (Cayman) LTD
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026
$1.96+0.06 (+3.16%)
Close on Oct 19, 2026
Cuprina Holdings (Cayman) LTD revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Maggot Debridement Therapy Product [Member] | 44.20K SGD | 34.42K SGD | 78.96K SGD | 56.60K SGD | 88.6% | +28.4% |
| Cosmeceutical Product [Member] | 5.69K SGD | 13.90K SGD | 21.82K SGD | – | 11.4% | -59.1% |
By product or service
By region
From the segment and revenue-disaggregation notes of Cuprina Holdings (Cayman)'s 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.